James N. Wilson, Director at CORCEPT THERAPEUTICS INC (CORT), sold 10,000 shares at $110.49 ($1.1M) on 2026-08-14, disclosed to the SEC on 2026-08-18.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.49 | 3,053 | $337K | 30.3% |
| 2 | $111.44 | 4,668 | $520K | 46.7% |
| 3 | $112.64 | 2,279 | $257K | 23.0% |
| Total | $111.43 avg | 10,000 | $1.1M | 100% |
| Filing → |
| CORT | SELL | 2026-06-18 | $832K | — | Filing → |
| CORT | SELL | 2016-11-14 | $1.4M | — | Filing → |
| CORT | SELL | 2016-01-06 | $6K | — | Filing → |